Justyna Godyń

1.4k total citations · 1 hit paper
35 papers, 1.1k citations indexed

About

Justyna Godyń is a scholar working on Pharmacology, Computational Theory and Mathematics and Molecular Biology. According to data from OpenAlex, Justyna Godyń has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 26 papers in Computational Theory and Mathematics and 16 papers in Molecular Biology. Recurrent topics in Justyna Godyń's work include Cholinesterase and Neurodegenerative Diseases (29 papers), Computational Drug Discovery Methods (26 papers) and Alzheimer's disease research and treatments (11 papers). Justyna Godyń is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (29 papers), Computational Drug Discovery Methods (26 papers) and Alzheimer's disease research and treatments (11 papers). Justyna Godyń collaborates with scholars based in Poland, Slovenia and Germany. Justyna Godyń's co-authors include Barbara Malawska, Dawid Panek, Jakub Jończyk, Anna Więckowska, Tomasz Wichur, Stanislav Gobec, Damijan Knez, Marek Bajda, Anna Pasieka and Ondřej Soukup and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Justyna Godyń

34 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic strategies for Alzheimer's disease in clinical trials

2015 356 citations Justyna Godyń, Jakub Jończyk et al. profile →

Peers

Countries citing papers authored by Justyna Godyń

Since Specialization

Citations

This map shows the geographic impact of Justyna Godyń's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justyna Godyń with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justyna Godyń more than expected).

Fields of papers citing papers by Justyna Godyń

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justyna Godyń. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justyna Godyń. The network helps show where Justyna Godyń may publish in the future.

Co-authorship network of co-authors of Justyna Godyń

This figure shows the co-authorship network connecting the top 25 collaborators of Justyna Godyń. A scholar is included among the top collaborators of Justyna Godyń based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justyna Godyń. Justyna Godyń is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of NLX-266, an Orally Available and Metabolically Stable ERK1/2-Biased 5-HT_1AR Agonist with Superior Antidepressant and Antiparkinsonian Activity 2025 ·Journal of Medicinal Chemistry ·Joanna Śniecikowska, Monika Głuch‐Lutwin, Adam Bucki, (unknown), Krzysztof Więckowski, Justyna Godyń, Anna Więckowska, Agata Siwek, Magdalena Jastrzębska‐Więsek, Anna Partyka, (unknown), Anna Wesołowska, Adrian Newman‐Tancredi, Marcin Kołaczkowski	0
2	4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H₃ Receptors and Cholinesterases 2024 ·ACS Chemical Neuroscience ·(unknown), (unknown), Justyna Godyń, (unknown), Marek Bajda, Tadeusz Karcz, (unknown), Holger Stark, Anna Więckowska, Krzysztof Walczyński, (unknown)	5
3	Exploring Novel GSK-3β Inhibitors for Anti-Neuroinflammatory and Neuroprotective Effects: Synthesis, Crystallography, Computational Analysis, and Biological Evaluation 2024 ·ACS Chemical Neuroscience ·(unknown), Tomasz Wichur, (unknown), (unknown), Monika Głuch‐Lutwin, Barbara Mordyl, Ewelina Honkisz-Orzechowska, (unknown), Justyna Godyń, Dawid Panek, Paula Zaręba, (unknown), Paweł Żmudzki, Gniewomir Latacz, Katarzyna Pustelny, Adam Bucki, Anna Czarna, Filipe Menezes, Anna Więckowska	5
4	Connecting GSK-3β Inhibitory Activity with IKK-β or ROCK-1 Inhibition to Target Tau Aggregation and Neuroinflammation in Alzheimer’s Disease—Discovery, In Vitro and In Cellulo Activity of Thiazole-Based Inhibitors 2024 ·Molecules ·(unknown), Tomasz Wichur, (unknown), Justyna Godyń, (unknown), Paula Zaręba, Monika Głuch‐Lutwin, Barbara Mordyl, Dawid Panek, Anna Więckowska	4
5	Discovery of new, highly potent and selective inhibitors of BuChE - design, synthesis, in vitro and in vivo evaluation and crystallography studies 2023 ·European Journal of Medicinal Chemistry ·Dawid Panek, Anna Pasieka, Gniewomir Latacz, Paula Zaręba, (unknown), Justyna Godyń, (unknown), Florian Nachon, Xavier Brazzolotto, (unknown), Maria Walczak, (unknown), Kinga Sałat, Georg Höfner, Klaus T. Wanner, Anna Więckowska, Barbara Malawska	9
6	Multitargeting Histamine H3 Receptor Ligands among Acetyl- and Propionyl-Phenoxyalkyl Derivatives 2023 ·Molecules ·Dorota Łażewska, (unknown), Paula Zaręba, Justyna Godyń, (unknown), Ewelina Honkisz-Orzechowska, (unknown), Anna Więckowska, Holger Stark, Katarzyna Kieć‐Kononowicz	4
7	Multifunctional agents against Alzheimer’s disease based on oxidative stress: Polysubstituted pyrazine derivatives synthesized by multicomponent reactions 2023 ·Bioorganic & Medicinal Chemistry ·(unknown), Lanlan Jing, Ye Tian, Anna Więckowska, Dongwei Kang, (unknown), Dawid Panek, Justyna Godyń, (unknown), Yuning Song, Xinyong Liu, Peng Zhan	4
8	Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect 2023 ·Pharmaceuticals ·(unknown), Magdalena Iwan, (unknown), Marek Bajda, Justyna Godyń, Gniewomir Latacz, Agnieszka Korga-Plewko, (unknown), (unknown), Holger Stark, Barbara Malawska, Anna Więckowska, Krzysztof Walczyński	4
9	Serotonin 5-HT6 Receptor Ligands and Butyrylcholinesterase Inhibitors Displaying Antioxidant Activity—Design, Synthesis and Biological Evaluation of Multifunctional Agents against Alzheimer’s Disease 2022 ·International Journal of Molecular Sciences ·Krzysztof Więckowski, (unknown), (unknown), Tomasz Wichur, (unknown), (unknown), Joanna Śniecikowska, Gniewomir Latacz, Agata Siwek, Justyna Godyń, Adam Bucki, Marcin Kołaczkowski, Anna Więckowska	7
10	Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT6 receptor with anti-aggregation properties against amyloid-beta and tau 2021 ·European Journal of Medicinal Chemistry ·Tomasz Wichur, Anna Pasieka, Justyna Godyń, Dawid Panek, (unknown), Gniewomir Latacz, Ewelina Honkisz-Orzechowska, Adam Bucki, Agata Siwek, Monika Głuch‐Lutwin, Damijan Knez, Xavier Brazzolotto, Stanislav Gobec, Marcin Kołaczkowski, Raimon Sabaté, Barbara Malawska, Anna Więckowska	21
11	Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT6R antagonists with β-amyloid anti-aggregation properties 2021 ·European Journal of Medicinal Chemistry ·Tomasz Wichur, Justyna Godyń, (unknown), Gniewomir Latacz, Adam Bucki, Agata Siwek, Monika Głuch‐Lutwin, Barbara Mordyl, Joanna Śniecikowska, Maria Walczak, Damijan Knez, Marko Jukič, Kinga Sałat, Stanislav Gobec, Marcin Kołaczkowski, Barbara Malawska, Xavier Brazzolotto, Anna Więckowska	19
12	Dual Action of Dipyridothiazine and Quinobenzothiazine Derivatives—Anticancer and Cholinesterase-Inhibiting Activity 2020 ·Molecules ·Jakub Jończyk, Justyna Godyń, (unknown), Beata Morak‐Młodawska, Małgorzata Jeleń, Krystian Pluta, Barbara Malawska	15
13	Multidirectional in vitro and in cellulo studies as a tool for identification of multi-target-directed ligands aiming at symptoms and causes of Alzheimer’s disease 2020 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown), Justyna Godyń, Jakub Jończyk, Anna Pasieka, Dawid Panek, Tomasz Wichur, Krzysztof Więckowski, Paula Zaręba, Marek Bajda, Anja Pišlar, Barbara Malawska, Raimon Sabaté, Anna Więckowska	15
14	Anti‐Alzheimer's multitarget‐directed ligands with serotonin 5‐HT₆ antagonist, butyrylcholinesterase inhibitory, and antioxidant activity 2019 ·Archiv der Pharmazie ·Monika Marcinkowska, Adam Bucki, Dawid Panek, Agata Siwek, (unknown), Marek Bednarski, Małgorzata Zygmunt, Justyna Godyń, (unknown), Magdalena Kotańska, Marcin Kołaczkowski, Anna Więckowska	19
15	1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer’s disease 2019 ·European Journal of Medicinal Chemistry ·Tomasz Wichur, Anna Więckowska, Krzysztof Więckowski, Justyna Godyń, Jakub Jończyk, (unknown), Dawid Panek, Anna Pasieka, Raimon Sabaté, Damijan Knez, Stanislav Gobec, Barbara Malawska	45
16	Design, Synthesis, and Biological Evaluation of 2-(Benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-Diones Derivatives as Potential Disease-Modifying Multifunctional Anti-Alzheimer Agents 2018 ·Molecules ·Dawid Panek, Anna Więckowska, Anna Pasieka, Justyna Godyń, Jakub Jończyk, Marek Bajda, Damijan Knez, Stanislav Gobec, Barbara Malawska	35
17	Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease 2018 ·ACS Chemical Neuroscience ·Anna Więckowska, Tomasz Wichur, Justyna Godyń, Adam Bucki, Monika Marcinkowska, Agata Siwek, Krzysztof Więckowski, Paula Zaręba, Damijan Knez, Monika Głuch‐Lutwin, Grzegorz Kazek, Gniewomir Latacz, (unknown), Marcin Kołaczkowski, Jan Korábečný, Ondřej Soukup, Markéta Benková, Katarzyna Kieć‐Kononowicz, Stanislav Gobec, Barbara Malawska	44
18	Design, Synthesis, and Biological Evaluation of 1-Benzylamino-2-hydroxyalkyl Derivatives as New Potential Disease-Modifying Multifunctional Anti-Alzheimer’s Agents 2018 ·ACS Chemical Neuroscience ·Dawid Panek, Anna Więckowska, Jakub Jończyk, Justyna Godyń, Marek Bajda, Tomasz Wichur, Anna Pasieka, Damijan Knez, Anja Pišlar, Jan Korábečný, Ondřej Soukup, Vendula Šepsová, Raimon Sabaté, Janko Kos, Stanislav Gobec, Barbara Malawska	49
19	Synthesis, Molecular Modelling and Biological Evaluation of Novel Heterodimeric, Multiple Ligands Targeting Cholinesterases and Amyloid Beta 2016 ·Molecules ·(unknown), Marek Bajda, Anna Więckowska, (unknown), Anna Pasieka, Dawid Panek, Justyna Godyń, Tomasz Wichur, Damijan Knez, Stanislav Gobec, Barbara Malawska	29
20	Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation 2016 ·European Journal of Medicinal Chemistry ·Anna Więckowska, Marcin Kołaczkowski, Adam Bucki, Justyna Godyń, Monika Marcinkowska, Krzysztof Więckowski, Paula Zaręba, Agata Siwek, Grzegorz Kazek, Monika Głuch‐Lutwin, Paweł Mierzejewski, Przemysław Bieńkowski, Halina Sienkiewicz‐Jarosz, Damijan Knez, Tomasz Wichur, Stanislav Gobec, Barbara Malawska	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact